Remicade and Tubal ligation - a phase IV clinical study of FDA data

Summary:

Tubal ligation is reported only by a few people who take Remicade.

The phase IV clinical study analyzes which people take Remicade and have Tubal ligation. It is created by eHealthMe based on reports of 201,081 people who have side effects while taking Remicade from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On May, 26, 2023

201,081 people reported to have side effects when taking Remicade.
Among them, 2 people (0.0%) have Tubal ligation.

What is Remicade?

Remicade has active ingredients of infliximab. It is often used in crohn's disease. eHealthMe is studying from 202,415 Remicade users for its effectiveness, alternative drugs and more.

What is Tubal ligation?

Tubal ligation is found to be associated with 78 drugs and 50 conditions by eHealthMe.

Number of Remicade and Tubal ligation reports submitted per year:

Gender of people who have Tubal ligation when taking Remicade *:

female: 100 %
male: 0.0 %

Age of people who have Tubal ligation when taking Remicade *:

Common side effects people have besides Tubal ligation *:

White Blood Cell Count Decreased: 2 people, 100.00%
Thrombocytopenia (decrease of platelets in blood): 2 people, 100.00%
Sepsis (a severe blood infection that can lead to organ failure and death): 1 person, 50.00%
Reticulocyte Count Decreased: 1 person, 50.00%
Infection: 1 person, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take Remicade and have Tubal ligation?

Check whether Tubal ligation is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Tubal ligation and when was it recovered:

Tubal ligation in Remicade

Expand to all the drugs that have ingredients of infliximab:

Tubal ligation and drugs with ingredients of infliximab

Alternative drugs to, pros and cons of Remicade:

Remicade (202,415 reports)

Common Remicade side effects:

Drug ineffective: 37,128 reports
Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints): 19,890 reports
Pain: 15,979 reports
Rashes (redness): 13,418 reports
Joint pain: 13,157 reports
Fatigue (feeling of tiredness): 12,449 reports
Joint swelling: 10,802 reports

Browse all side effects of Remicade:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Tubal ligation treatments and more:

Tubal ligation (77 reports)

COVID vaccines that are related to Tubal ligation:

All the drugs that are associated with Tubal ligation:

Tubal ligation (78 drugs)

All the conditions that are associated with Tubal ligation:

Tubal ligation (50 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on infliximab (the active ingredients of Remicade) and Remicade (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.